Echocardiography reporting in heart failure with preserved ejection fraction: Delphi consensus study
Diagnosis of HFpEF requires access to essential diagnostic tools. Establishing standardised pathways for specialist assessment and referral, including TTE reporting of HFpEF, may help eliminate diagnostic delays and geographical disparities. Further education and awareness are crucial for improving detection rates, prompt referral and patient experience.
Authors
- Maria F. Paton (ORCID: https://orcid.org/0000-0001-8517-4621)
- Rosita Zakeri (ORCID: https://orcid.org/0000-0002-4225-3693)
- Andrew Potter (ORCID: https://orcid.org/0000-0002-1012-2680)
- G Jenkins
- Resham Baruah (ORCID: https://orcid.org/0000-0001-7883-3633)
- Clare Taylor (ORCID: https://orcid.org/0000-0001-8926-2581)
- Nick Hartshorne‐Evans (ORCID: https://orcid.org/0000-0003-0356-1471)
- Rajan K. Thakkar (ORCID: https://orcid.org/0000-0002-2553-8574)
- Shaun Robinson
- Carys Barton
Institutions
- AstraZeneca (United Kingdom) (GB)
- Swansea Bay University Health Board (GB)
- University of Leeds (GB)
- Imperial College Healthcare NHS Trust (GB)
- King's College London (GB)
- Leeds Teaching Hospitals NHS Trust (GB)
- Milton Keynes Hospital (GB)
- King's College School (GB)
- The Society for Academic Primary Care (GB)
- University of Birmingham (GB)
Publication Details
- Journal
- Open Heart
- Published
- 2025-01-01
- DOI
- https://doi.org/10.1136/openhrt-2024-003063
- Citations
- 1
- Primary Topic
- Heart Failure Treatment and Management
- Type
- article
- Field-Weighted Citation Impact
- 1.39
Funders
- AstraZeneca